An increased IDO-1 production, mediated by, e.g., inflammatory conditions in response to T helper-1 cytokine interferon (IFN)-γ, protects healthy tissue in areas in which T cells are massively activated, e.g., in the tumor microenvironment [36,37,38]. Here, IDO1 is linked to neoplasm.